𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical phase II trial of recombinant dna interferon (interferon alfa 2b) in patients with metastatic malignant melanoma

✍ Scribed by Thierry Dorval; Thao Palangie; Michel Jouve; Emilio Garcia-Giralt; Lucien Israel; Ernesto Falcoff; Denis Schwab; Pierre Pouillart

Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
381 KB
Volume
58
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II clinical trial with 5-fluoroura
Phase II clinical trial with 5-fluorouracil, recombinant interferon-Ξ±-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus
✍ Scott Wadler; Hilda Haynes; Jonathan J. Beitler; Xiaoping Hu; Stanley Fell; Marg πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 393 KB πŸ‘ 1 views

## Background: Recombinant interferon-alpha (ifn) augments the cytotoxicity of both 5-fluorouracil (5-fu) and cisplatin in vitro. a phase ii study of 5-fu and ifn resulted in response rates of 25-27% in patients with metastatic esophageal carcinoma. ## Methods: A phase ii trial was initiated to d

A Phase II study of β€œdecrescendo” interl
A Phase II study of β€œdecrescendo” interleukin-2 plus interferon-Ξ±-2a in patients with progressive metastatic melanoma after chemotherapy
✍ Omar Eton; Antonio C. Buzaid; Agop Y. Bedikian; Teresa M. Smith; Nicholas E. Pap πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 81 KB

The authors tested a biotherapy regimen involving recombinant interferon-␣-2a (rIFN-␣-2a) and recombinant human interleukin-2 (rhIL-2), given in a "decrescendo" schedule over 5 days, for its activity and toxicity in 21 patients who previously had received chemotherapy for advanced melanoma. ## METH

A Phase II trial of 5-fluorouracil and r
A Phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma
✍ Richard Pazdur; Jaffer A. Ajani; Rodger Winn; James Bearden; Robert J. Belt; Sus πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 468 KB πŸ‘ 2 views

A Phase I1 clinical trial of the combination of 5-fluorouracil (5-FU) and recombinant alpha-2a-interferon (a-2a-IFN) was conducted in 44 patients. Patients had not received chemotherapy previously and had measurable metastatic gastric carcinoma. 5-FU was administered as a continuous infusion at a do